CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's ROI per quarter

Return on Investment, Quarterly Results, Trends, Rankings, Statistics


Return On Investment (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Investment Change -4.97 % -6.72 % -4.45 % -7.81 % -
Y / Y Net Income Change -75.17 % -54.47 % 7.52 % -1.15 % 52.37 %
Investment (TTM) in Millions 20,863 21,116 22,045 21,471 21,954
Return On Investment (TTM) 19 % 23.76 % 27.17 % 26.35 % 25.9 %
BIIB's Overall Ranking # 246 # 180 # 159 # 197 # 217
Seq. Investment Change -1.2 % -4.21 % 2.68 % -2.2 % -3.02 %
Seq. Net Income Change -49.21 % -56.18 % 15.36 % -3.27 % -6.87 %
Net Income (TTM) in Millions 4,061 5,143 5,985 5,872 5,889


Roi Comment
Biogen Inc achieved return on average invested assets of 19 % in IV. Quarter, above company average return on investment.

ROI decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 57 other companies have achieved higher return on investment. While Return on investment total ranking has deteriorated compare to previous quarter from 180 to 246.

Definition and Formula of Return on Investment
Return On Investment BIIB's Ranking
Within: No.
Industry # 11
Sector # 58
Overall # 246

Return On Investment Statistics
High Average Low
34.92 %
18.85 %
0.45 %
(Jun 30 2020)   (June 30. 2006)





Financial Statements
Biogen Inc 's forth quarter Investments $ 20,863 Millions BIIB's Balance sheet
Biogen Inc 's forth quarter Income $ 358 Millions Quarterly BIIB's Income Statement
BIIB's Income by Division See BIIB's Income by Division


BIIB Annual Return On Investment (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Investments in Millions 20,863 21,954 21,986 20,270 19,445
Y / Y Investment Growth -4.97 % -0.15 % 8.47 % 4.24 % 14.86 %
Net Income in Millions 4,061 5,889 4,474 2,670 3,696
Y / Y Net Income Growth -31.04 % 31.62 % 67.56 % -27.75 % 2.85 %
Annual Return On Investment 19.46 % 26.82 % 20.35 % 13.17 % 19.01 %


Annual Roi Comment
In the fiscal year 2020 ROI decreased compare to previous year to 19.46 %, due to detoriation of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Drugs Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BIIB's Roi Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for BIIB's Competitors
Roi for Biogen Inc 's Suppliers
Return On Investment for BIIB's Customers

Other Ratios
BIIB's Roa BIIB's Inventory Turnover Ratio BIIB's Growth Rates BIIB's Dividend Statistics
BIIB's Annual Roi BIIB's Profitability Ratios BIIB's Asset Turnover Ratio BIIB's Dividend Growth
BIIB's Roe BIIB's Valuation Ratios BIIB's Financial Strength Ratios BIIB's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2020, within Healthcare Sector ROI
Infusystem Holdings Inc  51.26 %
Coherus Biosciences inc   49.98 %
The Cooper Companies Inc   49.53 %
Hca Healthcare Inc   48.44 %
Siga Technologies Inc  48.31 %
Hologic Inc  44.81 %
Bionexus Gene Lab Corp  44.61 %
Zomedica Corp   44.31 %
Surface Oncology Inc   43.77 %
Viemed Healthcare Inc   43.75 %
Oramed Pharmaceuticals Inc   40.93 %
Eli Lilly And Company  39.15 %
Bio rad Laboratories Inc   37.29 %
Glaxosmithkline Plc  37.12 %
Amgen Inc   36.74 %
Zoetis Inc   36.39 %
Purple Biotech Ltd   34.79 %
Dexcom Inc   31.79 %
Vertex Pharmaceuticals Inc  31.04 %
Elite Pharmaceuticals Inc  30.54 %
Chemed Corporation  29.58 %
Regeneron Pharmaceuticals Inc   28.87 %
Lifevantage Corp  28.82 %
Biodelivery Sciences International Inc   28.04 %
Apollo Medical Holdings Inc   27.69 %
Blueprint Medicines Corporation  27.51 %
Biogen Inc   27.08 %
Meridian Bioscience Inc   25.22 %
Seagen Inc   25.20 %
Astrazeneca Plc  24.72 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

VSTR's Profile

Stock Price

VSTR's Financials

Business Description

Fundamentals

Charts & Quotes

VSTR's News

Suppliers

VSTR's Competitors

Customers & Markets

Economic Indicators

VSTR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071